Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

Autor: Darrell White, Gary J. Schiller, Sumit Madan, Suzanne Lentzsch, Evgeni Chubar, Noa Lavi, Dane R. Van Domelen, Ohad S. Bentur, Muhamed Baljevic

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

ObjectiveTo identify the optimal dose of selinexor in combination with pomalidomide and dexamethasone (SPd).MethodsAn analysis of efficacy and safety of 2 once-weekly selinexor regimens (60 mg and 40 mg) with pomalidomide and dexamethasone (SPd-60 an

Externí odkaz: https://doaj.org/article/faf3645ed4d642638bc528022e510fa6

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients

Autor: M. W. F. van Spengler, Ron A. A. Mathôt, Tim Preijers, Frank W.G. Leebeek, Marjon H. Cnossen, K. Fijnvandraat, Karina Meijer, Krista Fischer

Publikováno v: European Journal of Clinical Pharmacology, 78(2), 237-249. Springer-Verlag
European Journal of Clinical Pharmacology, 78(2), 237-249. Springer Verlag
European journal of clinical pharmacology, 78(2). Springer Verlag
European journal of clinical pharmacology, 78(2), 237-249. Springer Verlag
European Journal of Clinical Pharmacology

Purpose Hemophilia B is a bleeding disorder, caused by a factor IX (FIX) deficiency. Recently, FIX concentrates with extended half-life (EHL) have become available. Prophylactic dosing of EHL-FIX concentrates can be optimized by assessment of individ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f10d2a8fc4fb713c022f2191d679c460
http://www.scopus.com/inward/record.url?scp=85116989191&partnerID=8YFLogxK

Rx/Museum: A Weekly Dose of Art and Healing

Autor: Gordon Glantz

Publikováno v: ASA Monitor. 85:1-17

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b02364e385a922f0f9aa73dc6f44c890
https://doi.org/10.1097/01.asm.0000751444.92993.69

Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences?

Autor: Claudia Agabiti Rosei, Carlo Aggiusti, Fabio Bertacchini, Maria Lorenza Muiesan, Laura Andreoli, Franco Franceschini, Anna Paini, Deborah Stassaldi, Silvia Piantoni, Massimo Salvetti, Angela Tincani

Publikováno v: European Journal of Internal Medicine. 73:76-82

Objective to analyze the presence of cardiac and vascular preclinical damage in premenopausal women with systemic lupus erythematosus (SLE) and controls, matched for demographic characteristics and for other cardiovascular risk factors. Methods 33 wo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94cfa798b54f9f47ee87670b01b88ca9
https://doi.org/10.1016/j.ejim.2019.12.001

Anabolic Androgenic Steroids Induce Reversible Left Ventricular Hypertrophy and Cardiac Dysfunction. Echocardiography Results of the HAARLEM Study

Autor: Willem de Ronde, Diederik L. Smit, Martin den Heijer, A. J. Voogel

Publikováno v: Frontiers in reproductive health, 3
Smit, D L, Voogel, A J, den Heijer, M & de Ronde, W 2021, ' Anabolic Androgenic Steroids Induce Reversible Left Ventricular Hypertrophy and Cardiac Dysfunction. Echocardiography Results of the HAARLEM Study ', Frontiers in reproductive health, vol. 3, pp. 732318 . https://doi.org/10.3389/frph.2021.732318
Frontiers in Reproductive Health, Vol 3 (2021)

Background: The use of anabolic androgenic steroids (AAS) is not uncommon among strength athletes. Several cross-sectional studies have linked AAS use to heart disease, but a causal role for AAS is not certain and it is unknown whether cardiac change

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df7c872cb7ea462fd4e8d1bbf564275